SCHEMBL14015609

SCHEMBL14015609

COC(=O)c1cccc(C(=O)Oc2ccc(-c3ccc4c5c3CN(c3ccccc3OC)N5C(=O)C(C)(C)N4)c(OC)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.36
FAAH O00519 2/20 0.36
DRD3 P35462 2/20 0.36
IL6 P05231 6/20 0.35
LMNA P02545 3/20 0.34
MAPT P10636 3/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
HTT P42858 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
TP53 P04637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13639358 0.95 KMT2A (0.37) DRD2FAAHDRD3IL6LMNA
SCHEMBL13639336 0.91 HCRTR1 (0.37) DRD2FAAHDRD3IL6LMNA
SCHEMBL14015835 0.90 IL6 (0.39) DRD2FAAHDRD3IL6LMNA
SCHEMBL13639363 0.89 KMT2A (0.38) DRD2FAAHDRD3IL6MAPT
SCHEMBL14015597 0.89 MAPT (0.48) LMNAMAPTALDH1A1HTTTDP1
SCHEMBL13639362 0.89 HTR1A (0.37) DRD2FAAHDRD3IL6LMNA
SCHEMBL13639370 0.88 IL6 (0.38) DRD2FAAHDRD3IL6MAPT
SCHEMBL13639326 0.86 IL6 (0.38) DRD2IL6LMNAMAPTHTR1A
SCHEMBL14015605 0.86 KMT2A (0.36) IL6LMNAMAPTHTR1AALDH1A1
SCHEMBL14878774 0.86 ALOX15 (0.41) DRD2IL6LMNAMAPTHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1995242-A1 NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY Santen Pharmaceutical Co., Ltd (JP) 2008-11-26 EP disclosed